Thermo Fisher Scientific Inc (TMO) Financials

TMO Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 97.1 billion 51.5 billion
2023-12-31 98.7 billion 51.9 billion
2023-09-30 97.1 billion 51.6 billion
2023-06-30 94.1 billion 50.2 billion

TMO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 904.0 million ?
2023-12-31 3.3 billion 61.0 million
2023-09-30 2.1 billion -150.0 million
2023-06-30 1.3 billion -76.0 million

TMO Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 1.3 billion
2023-12-31 1.6 billion
2023-09-30 1.7 billion
2023-06-30 1.4 billion

TMO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 7.3 billion - -
2023-12-31 8.1 billion - -
2023-09-30 6.2 billion 30.5 billion -
2023-06-30 3.1 billion 29.2 billion -

TMO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 384.0 million
2023-12-31 388.0 million
2023-09-30 388.0 million
2023-06-30 388.0 million

TMO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 347.0 million 331.0 million - -
2023-12-31 405.0 million 327.0 million 2.1 billion -
2023-09-30 332.0 million 319.0 million 1.6 billion -
2023-06-30 284.0 million 345.0 million 1.7 billion -

TMO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 10.3 billion 6.6 billion
2023-12-31 10.9 billion 6.4 billion
2023-09-30 10.6 billion 6.1 billion
2023-06-30 10.7 billion 6.3 billion

TMO

List: Challengers

Price: $592.94

52 week price:
415.05
603.82

Dividend Yield: 0.27%

5-year range yield:
0.16%
0.30%

Forward Dividend Yield: 0.26%

Payout Ratio: 10.11%

Payout Ratio Range:
4.49%
16.50%

Dividend Per Share: 1.56 USD

Earnings Per Share: 15.43 USD

P/E Ratio: 35.82

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 1.2 million

Ebitda: 1.6 billion

Market Capitalization: 220.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 13

DGR3: 16.53%

DGR5: 15.07%

DGR10: 8.58%

Links: